BioHealth News Archive

Top AstraZeneca official says $200M biologics expansion is right for Maryland – Washington Business Journal

Top AstraZeneca official says $200M biologics expansion is right for Maryland – Washington Business Journal

When it came to deciding where drug giant AstraZeneca would expand its work making biologic medicines, there was no question the project would happen…

Read More
Roche immunotherapy improves lung cancer survival | Reuters

Roche immunotherapy improves lung cancer survival | Reuters

A mid-stage trial of Roche Holding AG's experimental immunotherapy showed that it doubled the likelihood of survival for lung cancer patients with the highest…

Read More

MedCity ENGAGE 2015 Tickets, Bethesda – Eventbrite

Tuesday, July 14, 2015 - Wednesday, July 15, 2015 - Bethesda, MD MedCity ENGAGE is an executive-level event featuring the most innovative thinking from…

Read More
Johns Hopkins has a plan to reduce the costs of cancer to businesses – Baltimore Business Journal

Johns Hopkins has a plan to reduce the costs of cancer to businesses – Baltimore Business Journal

Cancer is costly, pervasive and a growing problem for businesses. It already accounts for between 10 percent and 15 percent of employers' health costs.…

Read More
How one Germantown startup fought Ebola from the front lines, and the product it’s launching because of it – Washington Business Journal

How one Germantown startup fought Ebola from the front lines, and the product it’s launching because of it – Washington Business Journal

Luis Branco didn't originally plan to head to the front lines of the Ebola crisis. His Germantown-based startup, Zalgen Labs LLC, was testing its…

Read More
AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients

AstraZeneca (NYSE: AZN) announced that it has entered an agreement with Abbott (NYSE: ABT), a global healthcare company, to develop companion diagnostic tests to…

Read More
Oxford University, GSK, and Emergent BioSolutions Announce Initiation of a Prime Boost Study of Ebola Vaccine Candidates – NASDAQ.com

Oxford University, GSK, and Emergent BioSolutions Announce Initiation of a Prime Boost Study of Ebola Vaccine Candidates – NASDAQ.com

A new phase 1 study has begun at the University of Oxford that will investigate the use of a modified vaccinia Ankara (MVA) Ebola…

Read More
Korea unveils healthcare industry blueprint – Enterprise Innovation

Korea unveils healthcare industry blueprint – Enterprise Innovation

Korea’s Ministry of Health and Welfare unveiled a policy vision for the healthcare industry, which outlines the basic plan for each health sub-sector. Presented…

Read More
Health Datapalooza

Health Datapalooza

May 31-June 3, 2015 - Washington, DC Health Datapalooza is a national conference focused on liberating health data, and bringing together the companies, startups,…

Read More
How equity crowdfunding could bring more investment dollars to Maryland startups – Technical.ly Baltimore

How equity crowdfunding could bring more investment dollars to Maryland startups – Technical.ly Baltimore

As a serial entrepreneur who now runs an Israel-based platform that helps companies raise money from investors, Jon Medved has seen more than a…

Read More
Pieris Pharmaceuticals Appoints Former Celgene and Sanofi Executive, Jean-Pierre Bizzari, M.D., to Its Board of Directors :: Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals Appoints Former Celgene and Sanofi Executive, Jean-Pierre Bizzari, M.D., to Its Board of Directors :: Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals, Inc. (OTCQB: PIRS), a biotechnology company advancing its patented and proprietary Anticalin® biotherapeutic technologies, announced today that Jean-Pierre Bizzari, M.D., has joined…

Read More
Alexandria Real Estate Equities pumps more cash into San Francisco’s SoMa tech hub with 505 Brannan St. project – San Francisco Business Times

Alexandria Real Estate Equities pumps more cash into San Francisco’s SoMa tech hub with 505 Brannan St. project – San Francisco Business Times

One of the region’s biggest real estate investors just plunked down more money into the South of Market neighborhood that will soon give rise…

Read More
Baxter buys Sigma-Tau cancer drugs in $900m deal

Baxter buys Sigma-Tau cancer drugs in $900m deal

Baxter International is shelling out $900 million on Sigma-Tau’s Oncaspar (pegaspargase) product portfolio, in a move designed to strengthen its commercial foothold in the…

Read More
Baxter BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspar® Portfolio for Leukemia | Business Wire

Baxter BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspar® Portfolio for Leukemia | Business Wire

Baxter International Inc. (NYSE:BAX) announced it has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau Finanziaria S.p.A. The acquisition…

Read More
28 win prizes in third InvestMaryland Challenge – MDBIZNews

28 win prizes in third InvestMaryland Challenge – MDBIZNews

Congratulations to all the winners in the third InvestMaryland Challenge. All four will receive a $100,000 top prize from the Department of Business and…

Read More